High-throughput SNP/CGH approaches for the analysis of genomic instability in colorectal cancer

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 693, Issue 1-2, 2010, Pages 46-52

  Brenner, Bruce M ^a   Rosenberg, Daniel ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Colorectal cancer; Comparative genomic hybridization; Genomic instability; Loss of heterozygosity; Single nucleotide polymorphisms

Indexed keywords

CARCINOGENESIS; CHROMOSOMAL INSTABILITY; COLORECTAL CANCER; COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; CYTOGENETICS; DOWN REGULATION; GENE DOSAGE; GENE FREQUENCY; GENE MAPPING; GENE MUTATION; GENETIC ANALYSIS; GENETIC GAIN; GENOMIC INSTABILITY; HETEROZYGOSITY LOSS; HIGH THROUGHPUT SCREENING; HUMAN; MICROSATELLITE INSTABILITY; PATIENT CARE; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; UNIPARENTAL DISOMY;

COLORECTAL NEOPLASMS; COMPARATIVE GENOMIC HYBRIDIZATION; GENES, TUMOR SUPPRESSOR; GENOMIC INSTABILITY; HUMANS; ONCOGENES; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 78049415211     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2010.04.002     Document Type: Review

References (52)

1. Vogelstein B., Fearon E.R., Hamilton S.R., Kern S.E., Preisinger A.C., Leppert M., Nakamura Y., White R., Smits A.M., Bos J.L. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 1988, 319:525-532.
2. Loeb L.A. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 1991, 51:3075-3079.
3. Anderson G.R., Stoler D.L., Brenner B.M. Cancer: the evolved consequence of a destabilized genome. Bioessays 2001, 23:1037-1046.
4. Wood L.D., Parsons D.W., Jones S., Lin J., Sjoblom T., Leary R.J., Shen D., Boca S.M., Barber T., Ptak J., Silliman N., Szabo S., Dezso Z., Ustyanksky V., Nikolskaya T., Nikolsky Y., Karchin R., Wilson P.A., Kaminker J.S., Zhang Z., Croshaw R., Willis J., Dawson D., Shipitsin M., Willson J.K., Sukumar S., Polyak K., Park B.H., Pethiyagoda C.L., Pant P.V., Ballinger D.G., Sparks A.B., Hartigan J., Smith D.R., Suh E., Papadopoulos N., Buckhaults P., Markowitz S.D., Parmigiani G., Kinzler K.W., Velculescu V.E., Vogelstein B. The genomic landscapes of human breast and colorectal cancers. Science 2007, 318:1108-1113.
5. Knudson A.G. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. U.S.A. 1971, 68:820-823.
6. Vogelstein B., Fearon E.R., Kern S.E., Hamilton S.R., Preisinger A.C., Nakamura Y., White R. Allelotype of colorectal carcinomas. Science 1989, 244:207-211.
7. Laurent-Puig P., Olschwang S., Delattre O., Remvikos Y., Asselain B., Melot T., Validire P., Muleris M., Girodet J., Salmon R.J., et al. Survival and acquired genetic alterations in colorectal cancer. Gastroenterology 1992, 102:1136-1141.
8. Anderson G.R., Brenner B.M., Swede H., Chen N., Henry W.M., Conroy J.M., Karpenko M.J., Issa J.P., Bartos J.D., Brunelle J.K., Jahreis G.P., Kahlenberg M.S., Basik M., Sait S., Rodriguez-Bigas M.A., Nowak N.J., Petrelli N.J., Shows T.B., Stoler D.L. Intrachromosomal genomic instability in human sporadic colorectal cancer measured by genome-wide allelotyping and inter-(simple sequence repeat) PCR. Cancer Res. 2001, 61:8274-8283.
9. Brenner B.M., Stoler D.L., Rodriguez L., Karpenko M.J., Swede H., Petrelli N.J., Anderson G.R. Allelic losses at genomic instability-associated loci in villous adenomas and adjacent colorectal cancers. Cancer Genet. Cytogenet. 2007, 174:9-15.
10. Ishiguro K., Yoshida T., Yagishita H., Numata Y., Okayasu T. Epithelial and stromal genetic instability contributes to genesis of colorectal adenomas. Gut 2006, 55:695-702.
11. Luo L., Shen G.Q., Stiffler K.A., Wang Q.K., Pretlow T.G., Pretlow T.P. Loss of heterozygosity in human aberrant crypt foci (ACF), a putative precursor of colon cancer. Carcinogenesis 2006, 27:1153-1159.
12. Offerhaus G.J., De Feyter E.P., Cornelisse C.J., Tersmette K.W., Floyd J., Kern S.E., Vogelstein B., Hamilton S.R. The relationship of DNA aneuploidy to molecular genetic alterations in colorectal carcinoma. Gastroenterology 1992, 102:1612-1619.
13. Kallioniemi O.P., Kallioniemi A., Sudar D., Rutovitz D., Gray J.W., Waldman F., Pinkel D. Comparative genomic hybridization: a rapid new method for detecting and mapping DNA amplification in tumors. Semin. Cancer Biol. 1993, 4:41-46.
14. Ried T., Knutzen R., Steinbeck R., Blegen H., Schrock E., Heselmeyer K., du Manoir S., Auer G. Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer 1996, 15:234-245.
15. Nakao K., Shibusawa M., Tsunoda A., Yoshizawa H., Murakami M., Kusano M., Uesugi N., Sasaki K. Genetic changes in primary colorectal cancer by comparative genomic hybridization. Surg. Today 1998, 28:567-569.
16. De Angelis P.M., Clausen O.P., Schjolberg A., Stokke T. Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes. Br. J. Cancer 1999, 80:526-535.
17. Meijer G.A, Hermsen M.A., Baak J.P., van Diest P.J., Meuwissen S.G., Belien J.A., Hoovers J.M., Joenje H., Snijders P.J., Walboomers J.M. Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridisation. J. Clin. Pathol. 1998, 51:901-909.
18. Paredes-Zaglul A., Kang J.J., Essig Y.P., Mao W., Irby R., Wloch M., Yeatman T.J. Analysis of colorectal cancer by comparative genomic hybridization: evidence for induction of the metastatic phenotype by loss of tumor suppressor genes. Clin. Cancer Res. 1998, 4:879-886.
19. Al-Mulla F., Keith W.N., Pickford I.R., Going J.J., Birnie G.D. Comparative genomic hybridization analysis of primary colorectal carcinomas and their synchronous metastases. Genes Chromosomes Cancer 1999, 24:306-314.
20. Aragane H., Sakakura C., Nakanishi M., Yasuoka R., Fujita Y., Taniguchi H., Hagiwara A., Yamaguchi T., Abe T., Inazawa J., Yamagishi H. Chromosomal aberrations in colorectal cancers and liver metastases analyzed by comparative genomic hybridization. Int. J. Cancer 2001, 94:623-629.
21. De Angelis P.M., Stokke T., Beigi M., Mjaland O., Clausen O.P. Prognostic significance of recurrent chromosomal aberrations detected by comparative genomic hybridization in sporadic colorectal cancer. Int. J. Colorectal Dis. 2001, 16:38-45.
22. Nowak N.J., Miecznikowski J., Moore S.R., Gaile D., Bobadilla D., Smith D.D., Kernstine K., Forman S.J., Mhawech-Fauceglia P., Reid M., Stoler D., Loree T., Rigual N., Sullivan M., Weiss L.M., Hicks D., Slovak M.L. Challenges in array comparative genomic hybridization for the analysis of cancer samples. Genet. Med. 2007, 9:585-595.
23. Nakao K., Mehta K.R., Fridlyand J., Moore D.H., Jain A.N., Lafuente A., Wiencke J.W., Terdiman J.P., Waldman F.M. High-resolution analysis of DNA copy number alterations in colorectal cancer by array-based comparative genomic hybridization. Carcinogenesis 2004, 25:1345-1357.
24. Lassmann S., Weis R., Makowiec F., Roth J., Danciu M., Hopt U., Werner M. Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas. J. Mol. Med. 2007, 85:293-304.
25. Jones A.M., Douglas E.J., Halford S.E., Fiegler H., Gorman P.A., Roylance R.R., Carter N.P., Tomlinson I.P. Array-CGH analysis of microsatellite-stable, near-diploid bowel cancers and comparison with other types of colorectal carcinoma. Oncogene 2005, 24:118-129.
26. Jones A.M, Thirlwell C., Howarth K.M., Graham T., Chambers W., Segditsas S., Page K.M., Phillips R.K., Thomas H.J., Sieber O.M., Sawyer E.J., Tomlinson I.P. Analysis of copy number changes suggests chromosomal instability in a minority of large colorectal adenomas. J. Pathol. 2007, 213:249-256.
27. Habermann J.K., Paulsen U., Roblick U.J., Upender M.B., McShane L.M., Korn E.L., Wangsa D., Kruger S., Duchrow M., Bruch H.P., Auer G., Ried T. Stage-specific alterations of the genome, transcriptome, and proteome during colorectal carcinogenesis. Genes Chromosomes Cancer 2007, 46:10-26.
28. Carvalho B, Postma C., Mongera S., Hopmans E., Diskin S., van de Wiel M.A., van Criekinge W., Thas O., Matthai A., Cuesta M.A., Terhaar Sive Droste J.S., Craanen M., Schrock E., Ylstra B., Meijer G.A. Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression. Gut 2009, 58:79-89.
29. Stevens R.G., Swede H., Rosenberg D.W. Epidemiology of colonic aberrant crypt foci: review and analysis of existing studies. Cancer Lett. 2007, 252:171-183.
30. Alrawi S.J., Carroll R.E., Hill H.C., Gibbs J.F., Tan D., Brenner B.M., Nowak N.J., Swede H., Stoler D.L., Anderson G.R. Genomic instability of human aberrant crypt foci measured by inter-(simple sequence repeat) PCR and array-CGH. Mutat. Res. 2006, 601:30-38.
31. Zhao X., Li C., Paez J.G., Chin K., Janne P.A., Chen T.H., Girard L., Minna J., Christiani D., Leo C., Gray J.W., Sellers W.R., Meyerson M. An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. Cancer Res. 2004, 64:3060-3071.
32. Lips E.H., Dierssen J.W., van Eijk R., Oosting J., Eilers P.H., Tollenaar R.A., de Graaf E.J., van't Slot R., Wijmenga C., Morreau H., van Wezel T. Reliable high-throughput genotyping and loss-of-heterozygosity detection in formalin-fixed, paraffin-embedded tumors using single nucleotide polymorphism arrays. Cancer Res. 2005, 65:10188-10191.
33. Robinson W.P Mechanisms leading to uniparental disomy and their clinical consequences. Bioessays 2000, 22:452-459.
34. Melcher R., Zopf W., Hartmann E., Rosenwald A., Hoehn H., Schmid M., Kudlich T., Scheurlen M., Luehrs H. Spectral karyotyping and SNP microarray analysis define uniparental disomy (UPD) as a novel mutational mechanism in MSI- and CSI-colorectal cancers. Cell Oncol. 2008, 30:507.
35. Melcher R., Al-Taie O., Kudlich T., Hartmann E., Maisch S., Steinlein C., Schmid M., Rosenwald A., Menzel T., Scheppach W., Luhrs H. SNP-array genotyping and spectral karyotyping reveal uniparental disomy as early mutational event in MSS- and MSI-colorectal cancer cell lines. Cytogenet. Genome Res. 2007, 118:214-221.
36. Andersen C.L., Wiuf C., Kruhoffer M., Korsgaard M., Laurberg S., Orntoft T.F. Frequent occurrence of uniparental disomy in colorectal cancer. Carcinogenesis 2007, 28:38-48.
37. Gaasenbeek M., Howarth K., Rowan A.J., Gorman P.A., Jones A., Chaplin T., Liu Y., Bicknell D., Davison E.J., Fiegler H., Carter N.P., Roylance R.R., Tomlinson I.P. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex changes and multiple forms of chromosomal instability in colorectal cancers. Cancer Res. 2006, 66:3471-3479.
38. Lips E.H., de Graaf E.J., Tollenaar R.A., van Eijk R., Oosting J., Szuhai K., Karsten T., Nanya Y., Ogawa S., van de Velde C.J., Eilers P.H., van Wezel T., Morreau H. Single nucleotide polymorphism array analysis of chromosomal instability patterns discriminates rectal adenomas from carcinomas. J. Pathol. 2007, 212:269-277.
39. B.M. Brenner, D.W. Rosenberg, Evaluation of genomic instability in aberrant crypt foci using single nucleotide polymorphism arrays, Unpublished Data, 2010.
40. Cronin M., Sangli C., Liu M.L., Pho M., Dutta D., Nguyen A., Jeong J., Wu J., Langone K.C., Watson D. Analytical validation of the oncotype DX genomic diagnostic test for recurrence prognosis and therapeutic response prediction in node-negative, estrogen receptor-positive breast cancer. Clin. Chem. 2007, 53:1084-1091.
41. O'Connell M.J., Lavery I.C., Gray R.G., Quirke P., et al. Comparison of molecular and pathologic features of stage II and stage III colon cancer in four large studies conducted for development of the 12-gene recurrence score. Gastrointestinal Cancers Symposium 2010.
42. Gray R.G., Quirke P., Handley M., Lopatin L., et al. Correlation of number of nodes examined and the 12-gene colon cancer recurrence score with recurrence in stage II colon cancer patients from QUASAR. Gastrointestinal Cancers Symposium 2010.
43. Walther A., Houlston R., Tomlinson I. Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis. Gut 2008, 57:941-950.
44. Nakao M., Kawauchi S., Furuya T., Uchiyama T., Adachi J., Okada T., Ikemoto K., Oga A., Sasaki K. Identification of DNA copy number aberrations associated with metastases of colorectal cancer using array CGH profiles. Cancer Genet. Cytogenet. 2009, 188:70-76.
45. Postma C., Koopman M., Buffart T.E., Eijk P.P., Carvalho B., Peters G.J., Ylstra B., van Krieken J.H., Punt C.J., Meijer G.A. DNA copy number profiles of primary tumors as predictors of response to chemotherapy in advanced colorectal cancer. Ann. Oncol. 2009, 20:1048-1056.
46. Bacolod M.D., Schemmann G.S., Wang S., Shattock R., Giardina S.F., Zeng Z., Shia J., Stengel R.F., Gerry N., Hoh J., Kirchhoff T., Gold B., Christman M.F., Offit K., Gerald W.L., Notterman D.A., Ott J., Paty P.B., Barany F. The signatures of autozygosity among patients with colorectal cancer. Cancer Res. 2008, 68:2610-2621.
47. Sheffer M., Bacolod M.D., Zuk O., Giardina S.F., Pincas H., Barany F., Paty P.B., Gerald W.L., Notterman D.A., Domany E. Association of survival and disease progression with chromosomal instability: a genomic exploration of colorectal cancer. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:7131-7136.
48. Finishing the euchromatic sequence of the human genome. Nature 2004, 431:931-945.
49. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008, 455:1061-1068.
50. Mardis E.R. New strategies and emerging technologies for massively parallel sequencing: applications in medical research. Genome Med. 2009, 1:40.
51. Morozova O., Marra M.A. From cytogenetics to next-generation sequencing technologies: advances in the detection of genome rearrangements in tumors. Biochem. Cell Biol. 2008, 86:81-91.
52. Pleasance E.D., Stephens P.J., O'Meara S., McBride D.J., Meynert A., Jones D., Lin M.L., Beare D., Lau K.W., Greenman C., Varela I., Nik-Zainal S., Davies H.R., Ordonez G.R., Mudie L.J., Latimer C., Edkins S., Stebbings L., Chen L., Jia M., Leroy C., Marshall J., Menzies A., Butler A., Teague J.W., Mangion J., Sun Y.A., McLaughlin S.F., Peckham H.E., Tsung E.F., Costa G.L., Lee C.C., Minna J.D., Gazdar A., Birney E., Rhodes M.D., McKernan K.J., Stratton M.R., Futreal P.A., Campbell P.J. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 2010, 463:184-190.